Role of KATP Channel Loss in Type 2 Diabetes

NCT06830096 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Obesity and Type 2 Diabetes

Interventions

DRUG: 10 mg glipizide ingestion

Sponsor

Washington University School of Medicine

Collaborators

[object Object]